 |
|
|
| |
Treatment of genotype 3 cirrhotic patients
with 12 weeks of Sofosbuvir/Velpatasvir with or without Ribavirin:
Real life experience from Italy
|
| |
| |
Reported by Jules Levin
EASL 2019 April 10-14 Vienna
Luisa Pasulo, Martina Gambato, Angiola Spinetti, Roberta D´Ambrosio, Massimo Puoti, Alessia Ciancio, Vito Di Marco, Vincenza Calvaruso, Colombatto Piero,
Maurizia Brunetto, Monica Schiavini, Paolo Sacchi, Roberto Gulminetti, Giada Carolo, Piergiorgio Scotton, Caterina Pozzan, Maria Vinci, Mauro Viganò
on behalf Italian Real life HCV cirrhotic G3 Study Group (Navigatore Lombardy and Veneto, Piemonte, Tuscany, Sicily)
|
| |
|
|
|
|
|
